| Age and the effect of physical activity on breast cancer survival: a systematic review DBY Fontein, NA de Glas, M Duijm, E Bastiaannet, JEA Portielje, ... Cancer treatment reviews 39 (8), 958-965, 2013 | 66 | 2013 |
| Normal tissue complication probability modeling of pulmonary toxicity after stereotactic and hypofractionated radiation therapy for central lung tumors H Tekatli, M Duijm, E Oomen-de Hoop, W Verbakel, W Schillemans, ... International Journal of Radiation Oncology* Biology* Physics 100 (3), 738-747, 2018 | 48 | 2018 |
| Dose and volume of the irradiated main bronchi and related side effects in the treatment of central lung tumors with stereotactic radiotherapy M Duijm, W Schillemans, JG Aerts, B Heijmen, JJ Nuyttens Seminars in radiation oncology 26 (2), 140-148, 2016 | 46 | 2016 |
| Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy A Sharma, M Duijm, E Oomen-de Hoop, JG Aerts, C Verhoef, ... Acta Oncologica 58 (1), 74-80, 2019 | 43 | 2019 |
| Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy A Sharma, M Duijm, E Oomen-de Hoop, JG Aerts, C Verhoef, ... Acta Oncologica 57 (8), 1031-1037, 2018 | 36 | 2018 |
| Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy A Sharma, S Baker, M Duijm, E Oomen-de Hoop, R Cornelissen, ... Radiotherapy and Oncology 144, 23-29, 2020 | 26 | 2020 |
| Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma M Loi, M Duijm, S Baker, L Rossi, D Grunhagen, C Verhoef, J Nuyttens La radiologia medica 123, 871-878, 2018 | 24 | 2018 |
| Predicting high-grade esophagus toxicity after treating central lung tumors with stereotactic radiation therapy using a normal tissue complication probability model M Duijm, P van de Vaart, E Oomen-de Hoop, ME Mast, MS Hoogeman, ... International Journal of Radiation Oncology* Biology* Physics 106 (1), 73-81, 2020 | 21 | 2020 |
| Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling M Duijm, H Tekatli, E Oomen-de Hoop, W Verbakel, W Schillemans, ... Radiotherapy and Oncology 127 (2), 233-238, 2018 | 13 | 2018 |
| Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer S Baker, K Bakunina, M Duijm, MS Hoogeman, R Cornelissen, ... Radiation Oncology 15, 1-11, 2020 | 11 | 2020 |
| The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma M Duijm, E Oomen-de Hoop, NVV Van Der Zyp, P Van De Vaart, H Tekatli, ... Radiotherapy and Oncology 156, 223-230, 2021 | 9 | 2021 |
| Survival and prognostic factors of ultra-central tumors treated with stereotactic body radiotherapy V Salvestrini, M Duijm, M Loi, JJ Nuyttens Cancers 14 (23), 5908, 2022 | 5 | 2022 |
| Prognostic factors of local control and disease free survival in centrally located non-small cell lung cancer treated with stereotactic body radiation therapy M Duijm, NC van der Voort van Zyp, PV Granton, P van de Vaart, ME Mast, ... Acta Oncologica 59 (7), 809-817, 2020 | 5 | 2020 |
| The contribution of underdosage to the local control for central tumors in the lung treated with stereotactic radiation therapy M Duijm, J Nuyttens, W Schillemans, I Antonisse, MS Hoogeman, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), E465, 2016 | 2 | 2016 |
| Outcome and Toxicity Modelling after Stereotactic Radiotherapy of Central Lung Tumors M Duijm | 1 | 2021 |
| 2638: Toxicity analysis of high dose re-irradiation of in-field recurrent lung cancer: a prospective trial M Duijm, E Cammareri, PV Granton, W Schillemans, S Petit, J Belderbos, ... Radiotherapy and Oncology 194, S1761-S1763, 2024 | | 2024 |
| 740: High survival after high dose reirradiation of in-field recurrent lung cancer: a prospective trial M Duijm, E Cammareri, PV Granton, W Schillemans, S Petit, J Belderbos, ... Radiotherapy and Oncology 194, S1622-S1625, 2024 | | 2024 |
| Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: Clinical Outcome and Prognostic Factors V Salvestrini, M Duijm, M Loi, J Nuyttens International Journal of Radiation Oncology, Biology, Physics 117 (2), e52-e53, 2023 | | 2023 |
| PO-1329 Survival and prognostic factors of ultra-central tumors treated with stereotactic body radiotherapy V Salvestrini, M Duijm, M Loi, JJ Nuyttens Radiotherapy and Oncology 182, S1062-S1064, 2023 | | 2023 |
| Dose on cardiac (sub) structures as predictor for OS in early stage NSCLC patients treated with SBRT M Duijm, D Pezzulla, W Schillemans, J Nuyttens Radiotherapy and Oncology 152, S226-S227, 2020 | | 2020 |
